I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 26% ± 7% | |
| GABAergic neuron | 3 studies | 34% ± 12% | |
| glutamatergic neuron | 3 studies | 37% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 26% ± 7% | |
| GABAergic neuron | 3 studies | 34% ± 12% | |
| glutamatergic neuron | 3 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 3264.96 | 245 / 245 | 100% | 86.73 | 502 / 502 |
| esophagus | 100% | 1981.04 | 1445 / 1445 | 99% | 33.12 | 181 / 183 |
| ovary | 100% | 3066.32 | 180 / 180 | 99% | 26.79 | 425 / 430 |
| thymus | 100% | 1932.89 | 653 / 653 | 99% | 24.28 | 597 / 605 |
| lung | 99% | 1195.11 | 572 / 578 | 99% | 22.16 | 1138 / 1155 |
| stomach | 100% | 1364.56 | 359 / 359 | 97% | 31.56 | 278 / 286 |
| intestine | 100% | 2542.83 | 965 / 966 | 95% | 29.02 | 501 / 527 |
| uterus | 100% | 2452.84 | 170 / 170 | 95% | 21.61 | 434 / 459 |
| kidney | 100% | 1366.27 | 89 / 89 | 93% | 17.56 | 836 / 901 |
| brain | 94% | 986.05 | 2492 / 2642 | 98% | 19.92 | 691 / 705 |
| pancreas | 100% | 1423.58 | 327 / 328 | 92% | 13.18 | 163 / 178 |
| bladder | 100% | 2545.57 | 21 / 21 | 88% | 18.66 | 441 / 504 |
| adrenal gland | 98% | 752.41 | 253 / 258 | 74% | 9.29 | 171 / 230 |
| skin | 100% | 1378.92 | 1802 / 1809 | 63% | 8.11 | 296 / 472 |
| breast | 100% | 1551.30 | 459 / 459 | 52% | 9.86 | 583 / 1118 |
| liver | 83% | 554.16 | 187 / 226 | 58% | 7.18 | 235 / 406 |
| blood vessel | 100% | 3149.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1086.54 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3996.94 | 802 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1270.34 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 26.62 | 43 / 45 |
| heart | 94% | 1128.97 | 810 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 14.90 | 25 / 29 |
| eye | 0% | 0 | 0 / 0 | 48% | 6.11 | 38 / 80 |
| peripheral blood | 37% | 592.70 | 347 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046657 | Biological process | folic acid catabolic process |
| GO_0051246 | Biological process | regulation of protein metabolic process |
| GO_0006508 | Biological process | proteolysis |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0071713 | Molecular function | para-aminobenzoyl-glutamate hydrolase activity |
| GO_0004180 | Molecular function | carboxypeptidase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016805 | Molecular function | dipeptidase activity |
| Gene name | PM20D2 |
| Protein name | Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) |
| Synonyms | ACY1L2 |
| Description | FUNCTION: Catalyzes the peptide bond hydrolysis in dipeptides having basic amino acids lysine, ornithine or arginine at C-terminus. Postulated to function in a metabolite repair mechanism by eliminating alternate dipeptide by-products formed during carnosine synthesis. . |
| Accessions | ENST00000275072.5 Q8IYS1 |
